The Latest

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

By Barbara Jungwirth and Myles Helfand

Ketamine Use Linked to Liver and Other Problems in HIV-Positive People

Ketamine is a drug used as an anaesthetic in emergency departments of hospitals and by veterinarians. It can cause hallucinations, feelings of euphoria and floating, being in a dream-like state, out-of-body and other experiences. As a result, it is a...

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange